Related Experiment Video
Updated: Jun 18, 2025
08:30
A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
2.6K
Research Advances in Targeted Therapy for Heart Failure
1Department of Cardiology, Liuzhou People's Hospital, Affiliated of Guangxi Medical University, 545006 Liuzhou, Guangxi, China.
Reviews in Cardiovascular Medicine
|July 30, 2024
Summary
Cardiovascular diseases are a leading cause of death in China, with heart failure (HF) posing significant challenges. Further research into HF
Area of Science:
- Cardiovascular Medicine
- Gerontology
- Pathogenesis Research
Background:
- Cardiovascular disease (CVD) is the leading cause of mortality in China.
- Population aging exacerbates the prevalence and mortality of CVD.
- Current heart failure (HF) treatments and prognoses are suboptimal.
Purpose of the Study:
- To investigate the underlying mechanisms of heart failure.
- To identify novel therapeutic targets for heart failure.
- To improve outcomes for patients with cardiovascular disease.
Main Methods:
- This study focuses on exploring pathogenic mechanisms.
- Further details on specific methodologies are pending.
- Research will involve analyzing factors contributing to HF.
Main Results:
- Results are currently under investigation.
- Key findings regarding HF mechanisms will be presented.
- Identification of potential therapeutic targets is a primary outcome.
Conclusions:
- Understanding HF pathogenesis is crucial for improving patient outcomes.
- New therapeutic strategies are needed to address the rising burden of HF.
- This research aims to contribute to better cardiovascular disease management.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
01:22Heart Failure Drugs: β-Blockers
332
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
332
01:22Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
01:26Heart Failure Drugs: Inotropic Agents
555
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
555
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K